News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Pfizer Inc.'s Drug for Nerve Pain, Lyrica Gets Expanded Approval In Japan
October 29, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Oct 28 (Reuters) - Japanese health regulators approved Pfizer Inc's (PFE.N) Lyrica to treat a type of nerve pain called peripheral neuropathic pain, Pfizer said on Thursday.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
Pfizer
MORE ON THIS TOPIC
Regulatory
Makary Doubles Down on Push To ‘Modernize’ FDA, Eyes Speedier Reviews
June 18, 2025
·
2 min read
·
Tristan Manalac
Approvals
CSL Wins First Approval for Preventive Hereditary Angioedema Drug
June 18, 2025
·
2 min read
·
Tristan Manalac
FDA
FDA Rolls Out Commissioner’s Priority Voucher Program to Speed Drug Reviews
June 17, 2025
·
2 min read
·
Annalee Armstrong
Antibody-drug conjugate (ADC)
NextCure Joins China-ADC Gold Rush with $745M Simcere Deal
June 16, 2025
·
1 min read
·
Dan Samorodnitsky
